While genome-wide association studies of COVID-19 have not specifically linked G6PD polymorphic variants to severe illness (50), several retrospective studies have suggested that patients with G6PD deficiency were at increased risk of hospitalization and severe disease (51, 52), including acute respiratory distress syndrome with associated ventilator dependence (53). This evidence concerns the gene G6PD and G6PD deficiency.